AQP3

Chr 9

aquaporin 3 (Gill blood group)

Also known as: AQP-3, GIL

This gene encodes the water channel protein aquaporin 3. Aquaporins are a family of small integral membrane proteins related to the major intrinsic protein, also known as aquaporin 0. Aquaporin 3 is localized at the basal lateral membranes of collecting duct cells in the kidney. In addition to its water channel function, aquaporin 3 has been found to facilitate the transport of nonionic small solutes such as urea and glycerol, but to a smaller degree. It has been suggested that water channels can be functionally heterogeneous and possess water and solute permeation mechanisms. Alternative splicing of this gene results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2015]

Primary Disease Associations & Inheritance

[Blood group GIL]MIM #607457
0
Active trials
68
Pathogenic / LP
98
ClinVar variants
127
Pubs (1 yr)
1.6
Missense Z
0.64
LOEUF
Clinical SummaryAQP3
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.28) despite low pLI — interpret in context.
📋
ClinVar Variants
68 Pathogenic / Likely Pathogenic· 26 VUS of 98 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.64LOEUF
pLI 0.134
Z-score 2.51
OE 0.28 (0.140.64)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
1.58Z-score
OE missense 0.66 (0.570.77)
117 obs / 176.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.28 (0.140.64)
00.351.4
Missense OE0.66 (0.570.77)
00.61.4
Synonymous OE0.87
01.21.6
LoF obs/exp: 4 / 14.2Missense obs/exp: 117 / 176.2Syn Z: 0.94
GOFDN
DN
0.85top 5%
GOF
0.87top 5%
LOF
0.1796th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

98 submitted variants in ClinVar

Classification Summary

Pathogenic60
Likely Pathogenic8
VUS26
Likely Benign1
Benign3
60
Pathogenic
8
Likely Pathogenic
26
VUS
1
Likely Benign
3
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
60
0
60
Likely Pathogenic
0
0
8
0
8
VUS
0
21
5
0
26
Likely Benign
0
1
0
0
1
Benign
0
0
0
3
3
Total02273398

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

AQP3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Landmark / reviewRecent case evidence